ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 267 out of 1000

$417K Total Retail Price of All Prescriptions

Rank: 329 out of 1000

390 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 390 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 390 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 6,770 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 656 329 S3 1 1
LISINOPRIL 447 312 2 5
SIMVASTATIN 416 280 3 3
LEVOTHYROXINE SODIUM 399 329 4 4
OMEPRAZOLE 382 268 5 2
AMLODIPINE BESYLATE 336 234 6 6
METFORMIN HCL 240 153 7 8
PRAVASTATIN SODIUM 192 163 8 12
ATENOLOL 179 142 9 24
ZOLPIDEM TARTRATE 174 71 10 16
CITALOPRAM HBR 174 98 10 17
HYDROCHLOROTHIAZIDE 171 155 12 9
ATORVASTATIN CALCIUM 166 114 13 18
FUROSEMIDE 156 117 14 7
CARVEDILOL 144 127 15 15
METOPROLOL SUCCINATE 117 78 16 21
PANTOPRAZOLE SODIUM 116 88 17 28
GABAPENTIN 114 78 18 11
POTASSIUM CHLORIDE 107 98 19 10
LYRICA 104 58 20 47
ESCITALOPRAM OXALATE 96 46 21 60
LOSARTAN POTASSIUM 91 85 22 25
AZITHROMYCIN 87 60 23 36
TAMSULOSIN HCL 85 85 24 33
ENALAPRIL MALEATE 84 50 25 58
WARFARIN SODIUM 78 64 26 22
NEXIUM 76 43 27 23
AMLODIPINE BESYLATE-BENAZEPRIL 74 61 28 59
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 60 29 20
LOVASTATIN 70 56 30 41
PROAIR HFA 68 31 31 50
GLIMEPIRIDE 66 39 32 34
RANITIDINE HCL 65 30 33 37
METOPROLOL TARTRATE 65 58 33 19
AMPHETAMINE SALT COMBO 62 25 S2 35 223
GLIPIZIDE XL 60 58 36 138
LOSARTAN-HYDROCHLOROTHIAZIDE 60 48 36 38
CIPROFLOXACIN HCL 59 49 38 46
METFORMIN HCL ER 59 44 38 44
TRIAMTERENE-HCTZ 58 48 40 48
CLOPIDOGREL 57 38 41 35
TRAZODONE HCL 56 38 42 29
CRESTOR 56 44 42 30
FLUTICASONE PROPIONATE 56 30 42 40
KLOR-CON M20 56 37 42 66
GLYBURIDE-METFORMIN HCL 56 51 R 42 121
DONEPEZIL HCL 54 54 47 32
SERTRALINE HCL 54 36 47 26
GLIPIZIDE ER 53 27 49 106
ROPINIROLE HCL 50 37 50 82
AMOX TR-POTASSIUM CLAVULANATE 50 24 50 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.